PARP-inhibition with IFNg in the ovarian tumor microenvironment induces immunogenic cancer cell death for sustained anti-tumor immunity.

被引：0
|
作者：
Kinjyo, Ichiko
Adams, Sarah F.
机构：
来源：
JOURNAL OF IMMUNOLOGY | 2022年 / 208卷 / 01期
关键词：
D O I：
10.4049/jimmunol.208.Supp.176.15
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
176.15
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Targeting ENPP1 to boost anti-tumor immunity during PARP inhibition
    Li, Jie
    Mason, Charlotte
    Hanggi, Kay
    Luca, Vincent
    Ruffell, Brian
    CANCER RESEARCH, 2023, 83 (07)
  • [22] PV 10 induces endoplasmic reticulum stress and autophagy, triggering immunogenic cell death and anti-tumor immunity in head and neck squamous cell carcinoma
    Thatikonda, Sowjanya
    Chaudhary, Ritu
    Meshkovska, Yeva
    Biernacki, Maria I.
    Slebos, Robbert
    Thomas, Shari P.
    Antonio, Amelio L.
    Wachter, Eric A.
    Chung, Christine H.
    CANCER RESEARCH, 2024, 84 (06)
  • [23] Ovarian cancer ascites induces a T cell suppressive phenotype in mature neutrophils: a potential barrier to anti-tumor immunity
    Singel, Kelly L.
    Anm, Nazmul H. Khan
    Moysich, Kirsten B.
    Odunsi, Kunle
    Segal, Brahm H.
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [24] Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer
    Goebel, Andy
    Zinna, Valentina M.
    Dell'Endice, Stefania
    Jaschke, Nikolai
    Kuhlmann, Jan Dominik
    Wimberger, Pauline
    Rachner, Tilman D.
    BMC CANCER, 2020, 20 (01)
  • [25] Inhibition of MMP9 improves anti-tumor immunity by changing the tumor microenvironment to promote T cell trafficking and activation
    Juric, Vladi
    Mikels-Vigdal, Amanda
    O'Sullivan, Chris
    Greenstein, Andrew
    Stefanutti, Erin
    Barry-Hamilton, Vivian
    Mikaelian, Igor
    Sullivan, Ted
    Huntzicker, Erik
    Degenhardt, Jeremiah
    Yue, Peng
    Smith, Victoria
    CANCER RESEARCH, 2017, 77
  • [26] Anti-tumor effects in combination with PARP inhibitor and DNMT inhibitor in ovarian cancer
    Lee, Jeong-Won
    Jeong, Soo Young
    Ryu, Ji Yoon
    Lee, Yoo-Young
    Esun, Paik
    CANCER RESEARCH, 2019, 79 (13)
  • [27] Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer
    Andy Göbel
    Valentina M. Zinna
    Stefania Dell’Endice
    Nikolai Jaschke
    Jan Dominik Kuhlmann
    Pauline Wimberger
    Tilman D. Rachner
    BMC Cancer, 20
  • [28] Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity
    Aaes, Tania Love
    Kaczmarek, Agnieszka
    Delvaeye, Tinneke
    De Craene, Bram
    De Koker, Stefaan
    Heyndrickx, Liesbeth
    Delrue, Iris
    Taminau, Joachim
    Wiernicki, Bartosz
    De Groote, Philippe
    Garg, Abhishek D.
    Leybaert, Luc
    Grooten, Johan
    Bertrand, Mathieu J. M.
    Agostinis, Patrizia
    Berx, Geert
    Declercq, Wim
    Vandenabeele, Peter
    Krysko, Dmitri V.
    CELL REPORTS, 2016, 15 (02): : 274 - 287
  • [29] Fostriecin potentiates genome instability and anti-tumor immunity in ovarian cancer
    Raja, R.
    Wu, C.
    Butler, K.
    Curtis, M.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S61 - S61
  • [30] FOSTRIECIN POTENTIATES GENOME INSTABILITY AND ANTI-TUMOR IMMUNITY IN OVARIAN CANCER
    Raja, Remya
    Wu, Christopher
    Butler, Kristina
    Curtis, Marion
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A337 - A337
12345